These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7902024)

  • 1. A comparison of topical levocabastine and oral terfenadine in the treatment of allergic rhinoconjunctivitis. The Livostin Study Group.
    Allergy; 1993 Oct; 48(7):530-4. PubMed ID: 7902024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical levocabastine compared with orally administered terfenadine for the prophylaxis and treatment of seasonal rhinoconjunctivitis.
    Søhoel P; Freng BA; Kramer J; Poppe S; Rebo R; Korsrud FR; Garud O; Woxen OJ; Olsen AK
    J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):73-81. PubMed ID: 8101534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of topical levocabastine compared with oral terfenadine.
    Bahmer FA; Ruprecht KW
    Ann Allergy; 1994 May; 72(5):429-34. PubMed ID: 7909999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical levocabastine--an effective alternative to oral antihistamines in seasonal allergic rhinoconjunctivitis.
    Bahmer FA
    Clin Exp Allergy; 1995 Mar; 25(3):220-7. PubMed ID: 7788568
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical levocabastine compared with oral loratadine for the treatment of seasonal allergic rhinoconjunctivitis. Swedish GP Allergy Team.
    Allergy; 1994 Sep; 49(8):611-5. PubMed ID: 7653738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
    Noble S; McTavish D
    Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical levocabastine, a selective H1 antagonist, in seasonal allergic rhinoconjunctivitis.
    Bende M; Pipkorn U
    Allergy; 1987 Oct; 42(7):512-5. PubMed ID: 2891316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children.
    Vermeulen J; Mercer M
    Pediatr Allergy Immunol; 1994 Nov; 5(4):209-13. PubMed ID: 7894627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen-provoked allergic conjunctivitis.
    Frostad AB; Olsen AK
    Clin Exp Allergy; 1993 May; 23(5):406-9. PubMed ID: 8101467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
    Janssens MM
    Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of levocabastine eye drops.
    Janssens M; Blockhuys S
    Doc Ophthalmol; 1993; 84(2):111-8. PubMed ID: 7905376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis.
    Odelram H; Björkstén B; af Klercker T; Rimås M; Kjellman NI; Blychert LO
    Allergy; 1989 Aug; 44(6):432-6. PubMed ID: 2572181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis.
    Verin P; Easty DL; Secchi A; Ciprandi G; Partouche P; Nemeth-Wasmer G; Brancato R; Harrisberg CJ; Estivin-Ebrardt C; Coster DJ; Apel AJ; Coroneo MT; Knorr M; Carmichael TR; Kent-Smith BT; Abrantes P; Leonardi A; Cerqueti PM; Modorati G; Martinez M
    Am J Ophthalmol; 2001 Jun; 131(6):691-8. PubMed ID: 11384563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onset of action, effectiveness and tolerance of levocabastine and nedocromil in topical therapy of seasonal allergic rhinoconjunctivitis. The Deutsche Rhinitis-Studiengruppe.
    Kremer B; Tündermann A; Goldschmidt O
    Arzneimittelforschung; 1998 Sep; 48(9):924-30. PubMed ID: 9793620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of levocabastine nasal spray for seasonal allergic rhinitis.
    Hampel FC; Martin BG; Dolen J; Travers S; Karcher K; Holton D
    Am J Rhinol; 1999; 13(1):55-62. PubMed ID: 10088031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind evaluation of topical levocabastine, a new specific H1 antagonist in patients with allergic conjunctivitis.
    Pipkorn U; Bende M; Hedner J; Hedner T
    Allergy; 1985 Oct; 40(7):491-6. PubMed ID: 2866725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model.
    Netland PA; Leahy C; Krenzer KL
    Am J Ophthalmol; 2000 Dec; 130(6):717-23. PubMed ID: 11124289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
    Falser N; Wober W; Rahlfs VW; Baehre M
    Arzneimittelforschung; 2001; 51(5):387-93. PubMed ID: 11413739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitis.
    Abelson MB; Weintraub D
    Eur J Ophthalmol; 1994; 4(2):91-101. PubMed ID: 7950341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis.
    Davies BH; Mullins J
    Allergy; 1993 Oct; 48(7):519-24. PubMed ID: 7902022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.